Research Article
Volume 3 Issue 11 - 2020
Meta-Analysis and Rationale Regarding the Effect of Protease Inhibitors on Survival in the HIV-1-Infected Population
Kevin D Pruitt1 and Nicholas A Kerna2*
1Kemet Medical Consultants, USA
2SMC–Medical Research, Thailand
*Corresponding Author: Nicholas A Kerna, POB47 Phatphong, Suriwongse Road, Bangkok, Thailand.
Received: August 20, 2020; Published: October 29, 2020




Abstract

One of the most effective ways to decrease the replication of HIV and viral load in HIV-infected patients is to inhibit the protease enzyme system. Medications that inhibit the HIV protease enzyme system have been shown to decrease mortality. Protease inhibitors attack a vital point in the viral replication cycle of HIV. Medical research has shown that this class of drugs increases survival and decreases morbidity in the HIV-infected population. However, protease inhibitors have specific side effects, adversely affecting patient compliance and increasing comorbidities and mortality. The first-generation of HIV drugs (and treatment regimes) have been replaced by newer drugs and drug combinations, resulting in fewer side effects and higher compliance rates. This paper presents the results and rationale of a meta-analysis regarding the effect of protease inhibitors on survival in the HIV-1-infected population. The current use of protease inhibitors—although not a cure for HIV/AIDS—is beneficial in controlling HIV and decreasing associated mortality and morbidity.

Keywords: AIDS; Immunodeficiency; HIV; Human Immunodeficiency Virus; Mortality; Protease Inhibitor; Survival

References

  1. Hedges LV and Vevea JL. “Fixed-and random-effects models in meta-analysis”. Psychological Methods4 (1998): 486-504. https://psycnet.apa.org/record/1998-11538-006
  2. Brown S., et al. “A framework for developing a coding scheme for meta-analysis”. Western Journal of Nursing Research2 (2003): 205-222. https://www.researchgate.net/publication/10829007_A_Framework_for_Developing_a_Coding_Scheme_for_Meta-Analysis
  3. Rudestam KE and Newton RR. “Surviving your dissertation: A comprehensive guide to content and process (3rd edition)”. Thousand Oaks, CA: Sage (2007).
  4. Frankfort-Nachmias C and Nachmias D. “Research methods in the social sciences (7th edition)”. New York, NY: Worth. Gagliardini., et al. R. (2016). Simplification to atazanavir/ritonavir + lamivudine
  5. Cresswell F., et al. “Achilles tendinopathy following Kaletra (lopinavir/ritonavir) use”. International Journal of STD and AIDS 25.11 (2014): 833-835. https://pubmed.ncbi.nlm.nih.gov/24516081/
  6. Borenstein M., et al. “A basic introduction to fixed and random-effects models for meta-analysis”. Research Synthesis Methods (2010): 97-111. https://www.meta-analysis.com/downloads/Intro_Models.pdf
  7. Creswell J. “Research design: Qualitative, quantitative, and mixed methods approaches”. Thousands Oaks, CA: SAGE (2009).
  8. Chow SL. “Sigruficance test or effect size)”. Psychological Bulletin 103 (1988): 105-110. https://psycnet.apa.org/record/1988-09585-001
  9. Cohen J. “Some statistical Issues m psychological research”. In BB Wolman (Edition.), Handbook of clinical psychology. New York: McGraw-Hill (1965).
  10. Cohen, J. (1969). Statistical power analysis for the behavioral sciences”. New York. Academic Press. COHEN J. “Statistical power analysis for the behavioral sciences (rev. edition.) New York: Academic Press (1977).
  11. Cohen J. “Statistical power analysis or the behavioral sciences (2nd)”. New York: Academic Press (1988).
  12. Hedges L., et al. “Robust variance estimation in meta-regression with dependent effect size estimates”. Research Synthesis Methods (2010): 39-65. https://pubmed.ncbi.nlm.nih.gov/26056092/
  13. Ford N., et al. “Comparative safety and neuropsychiatric adverse events associated with efavirenz use in first-line antiretroviral therapy: A systematic review and meta-analysis of randomized trials”. Journal of Acquired Immune Deficiency Syndromes 4 (2015): 422-429. https://pubmed.ncbi.nlm.nih.gov/25850607/
  14. DerSimonian R and Kacker R. “Random-effects model for meta-anaylsis of clinical trials: An update”. Contemporary Clinical Trials 28 (2007): 105-114. https://pubmed.ncbi.nlm.nih.gov/16807131/
  15. Brockwell SE and Gordon IR. “A comparison of statistical methods for meta-analysis”. Statistics in Medicine 20 (2001): 825-840. https://pubmed.ncbi.nlm.nih.gov/11252006/
  16. Higgins J and Thompson S. “Quantifying heterogeneity in a meat-analysis”. Statistics in Medicine 21 (2002): 1539-1558. https://onlinelibrary.wiley.com/doi/abs/10.1002/sim.1186
  17. Moher D., et al. “Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement”. The Annals of Internal Medicine4 (2009): 264-270. https://www.bmj.com/content/339/bmj.b2535
  18. Shubber Z., et al. “Adverse events associated with nevirapine and efavirenz-based first-line antiretroviral therapy: a systematic review and meta-analysis”. AIDS9 (2013): 1403-1412. https://pubmed.ncbi.nlm.nih.gov/23343913/
  19. Brechtl J., et al. “The use of highly active antiretroviral therapy (HAART) in patients with advanced HIV infection: Impact on mecial, palliative care, and quality of life outcomes”. Journal od Pain and Symptom Management 21 (2001): 41-51. https://www.sciencedirect.com/science/article/pii/S0885392400002451
  20. Chirouze C., et al. “Viremia copy-years as a predictive marker of all-cause mortality in HIV-1-infecting patients initiating a protease inhibitor-containing antiretroviral treatment”. JAIDS Journal of Acquired Immune Deficiency Syndromes 68 (2015): 204-208. https://europepmc.org/article/med/25590273
  21. Zhigang Z., et al. “Impact of antiretroviral therapy on mid-and-long term survival among people living with HIV/AIDS in Guangxi, Southern China- A cohort study”. European Journal of Internal Medicine 37 (2016): e40-e43. https://pubmed.ncbi.nlm.nih.gov/27742390/
  22. Casado J. “Renal and bone toxicity with the use of tenofovir: understanding at the end”. AIDS Reviews 2 (2016): 59-68. https://pubmed.ncbi.nlm.nih.gov/27230467/
  23. Katz IT and Maughan-Brown B. “Improved life expectancy of people living with HIV: who is left behind?”. Lancet HIV 8 (2017): e324-e326. https://pubmed.ncbi.nlm.nih.gov/28501496/
  24. Mills E., et al. “Life expectancy of persons receiving combination antiretroviral therapy in low-income countries: A cohort analysis from Uganda”. Annals of Internal Medicine 155 (2011): 209-216. https://www.acpjournals.org/doi/10.7326/0003-4819-155-4-201108160-00358
Citation: Pruitt KD, Kerna NA. Meta-Analysis and Rationale Regarding the Effect of Protease Inhibitors on Survival in the HIV-1-Infected Population. EC Clinical and Medical Case Reports. 2020 Oct 1; 3.11: 43-61.

PubMed Indexed Article


EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005


EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777


EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347


EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478


EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253


EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033


EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992


EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505


EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793


EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211


EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047


EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560


EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318


EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819


EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840


EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344


EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476


EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658


EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489


EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278


EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108


EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571


EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333


EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883


EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001


EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937


EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723


EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726


EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603


EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646


EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616


EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290


EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226


EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812


EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268


News and Events


April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before April 22, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to editor@ecronicon.uk